-
Bringing Imaging Biomarkers Into Clinical Reality in Psychiatry JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-04 Amit Etkin, Daniel H. Mathalon
ImportanceAdvancing precision psychiatry, where treatments are based on an individual’s biology rather than solely their clinical presentation, requires attention to several key attributes for any candidate biomarker. These include test-retest reliability, sensitivity to relevant neurophysiology, cost-effectiveness, and scalability. Unfortunately, these issues have not been systematically addressed
-
Risk of Suicide Across Medical Conditions and the Role of Prior Mental Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-04 Søren Dinesen Østergaard, Natalie C. Momen, Uffe Heide-Jørgensen, Oleguer Plana-Ripoll
ImportanceAccording to the World Health Organization, more than 700 000 individuals worldwide die by suicide each year. Medical conditions likely increase the risk of suicide.ObjectiveTo (1) provide age- and sex-specific pairwise estimates of the risk of suicide across a comprehensive range of medical conditions, (2) investigate whether there is a dose-response–like relationship at play (ie, the higher
-
Commercial Interests and EEG Data Collection. JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-04 Dost Ongur
-
Adverse Events in Studies of Classic Psychedelics JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-04 Jared T. Hinkle, Marianna Graziosi, Sandeep M. Nayak, David B. Yaden
ImportanceA clear and comprehensive understanding of risks associated with psychedelic-assisted therapy is necessary as investigators extend its application to new populations and indications.ObjectiveTo assess adverse events (AEs) associated with classic psychedelics, particularly serious AEs (SAEs) and nonserious AEs (NSAEs) requiring medical or psychiatric evaluation.Data SourcesThe search for potentially
-
Psychiatric Symptoms, Cognition, and Symptom Severity in Children JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-28 Adam Pines, Leonardo Tozzi, Claire Bertrand, Arielle S. Keller, Xue Zhang, Susan Whitfield-Gabrieli, Trevor Hastie, Bart Larsen, John Leikauf, Leanne M. Williams
ImportanceMental illnesses are a leading cause of disability globally, and functional disability is often in part caused by cognitive impairments across psychiatric disorders. However, studies have consistently reported seemingly opposite findings regarding the association between cognition and psychiatric symptoms.ObjectiveTo determine if the association between general cognition and mental health
-
Polygenic Risk Scores and Twin Concordance for Schizophrenia and Bipolar Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-28 Jie Song, Joëlle A. Pasman, Viktoria Johansson, Ralf Kuja-Halkola, Arvid Harder, Robert Karlsson, Yi Lu, Kaarina Kowalec, Nancy L. Pedersen, Tyrone D. Cannon, Christina M. Hultman, Patrick F. Sullivan
ImportanceSchizophrenia and bipolar disorder are highly heritable psychiatric disorders with strong genetic and phenotypic overlap. Twin and molecular methods can be leveraged to predict the shared genetic liability to these disorders.ObjectiveTo investigate whether twin concordance for psychosis depends on the level of polygenic risk score (PRS) for psychosis and zygosity and compare PRS from cases
-
COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-21 Venexia M Walker,Praveetha Patalay,Jose Ignacio Cuitun Coronado,Rachel Denholm,Harriet Forbes,Jean Stafford,Bettina Moltrecht,Tom Palmer,Alex Walker,Ellen J Thompson,Kurt Taylor,Genevieve Cezard,Elsie M F Horne,Yinghui Wei,Marwa Al Arab,Rochelle Knight,Louis Fisher,Jon Massey,Simon Davy,Amir Mehrkar,Seb Bacon,Ben Goldacre,Angela Wood,Nishi Chaturvedi,John Macleod,Ann John,Jonathan A C Sterne,
Importance Associations have been found between COVID-19 and subsequent mental illness in both hospital- and population-based studies. However, evidence regarding which mental illnesses are associated with COVID-19 by vaccination status in these populations is limited. Objective To determine which mental illnesses are associated with diagnosed COVID-19 by vaccination status in both hospitalized patients
-
Trajectories of Inflammation in Youth and Risk of Mental and Cardiometabolic Disorders in Adulthood JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-21 Edward R. Palmer, Isabel Morales-Muñoz, Benjamin I. Perry, Steven Marwaha, Ella Warwick, Jack C. Rogers, Rachel Upthegrove
ImportanceResearch suggests that low-grade, nonresolving inflammation may predate adult mental and physical illness. However, evidence to date is largely cross-sectional or focuses on single disorder outcomes.ObjectivesTo examine trajectories of inflammation as measured by C-reactive protein (CRP) levels in a large sample of children and adolescents, and to explore associations between different identified
-
Inflammatory Biomarkers and Risk of Psychiatric Disorders JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-21 Yu Zeng, Charilaos Chourpiliadis, Niklas Hammar, Christina Seitz, Unnur A. Valdimarsdóttir, Fang Fang, Huan Song, Dang Wei
ImportanceIndividuals with psychiatric disorders have been reported to have elevated levels of inflammatory biomarkers, and prospective evidence is limited regarding the association between inflammatory biomarkers and subsequent psychiatric disorders risk.ObjectiveTo assess the associations between inflammation biomarkers and subsequent psychiatric disorders risk.Design, Setting, and ParticipantsThis
-
Semaglutide in Psychiatry—Opportunities and Challenges JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-21 Sri Mahavir Agarwal, Margaret Hahn
This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.
-
Mental Health Diagnoses in People Experiencing Homelessness-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-14 Rebecca Barry,Dallas Seitz
-
Mental Health Diagnoses in People Experiencing Homelessness. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-14 Kevin Y Xu,Sonya E Gabrielian,Tashalee R Brown
-
Mental Health Care Support in Rural India JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-14 Pallab K. Maulik, Mercian Daniel, Siddhardha Devarapalli, Sudha Kallakuri, Amanpreet Kaur, Arpita Ghosh, Laurent Billot, Ankita Mukherjee, Rajesh Sagar, Sashi Kant, Susmita Chatterjee, Beverley M. Essue, Usha Raman, Devarsetty Praveen, Graham Thornicroft, Shekhar Saxena, Anushka Patel, David Peiris
ImportanceMore than 150 million people in India need mental health care but few have access to affordable care, especially in rural areas.ObjectiveTo determine whether a multifaceted intervention involving a digital health care model along with a community-based antistigma campaign leads to reduced depression risk and lower mental health–related stigma among adults residing in rural India.Design, Setting
-
Hyperalgesia in Patients With a History of Opioid Use Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-14 Martin Trøstheim, Marie Eikemo
ImportanceShort-term and long-term opioid treatment have been associated with increased pain sensitivity (ie, opioid-induced hyperalgesia). Treatment of opioid use disorder (OUD) mainly involves maintenance with methadone and buprenorphine, and observations of heightened cold pain sensitivity among patients are often considered evidence of opioid-induced hyperalgesia.ObjectiveTo critically examine
-
Training Psychiatrist-Scientists-Excellence on Both Sides of the Hyphen. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-07 Jacob L Taylor,James B Potash
-
Unveiling the Structure in Mental Disorder Presentations JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-07 Tobias R. Spiller, Or Duek, Markus Helmer, John D. Murray, Elliot Fielstein, Robert H. Pietrzak, Roland von Känel, Ilan Harpaz-Rotem
ImportanceDSM criteria are polythetic, allowing for heterogeneity of symptoms among individuals with the same disorder. In empirical research, most combinations were not found or only rarely found, prompting criticism of this heterogeneity.ObjectiveTo elaborate how symptom-based definitions and assessments contribute to a distinct probability pattern for the occurrence of symptom combinations.Design
-
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-07 Gil Grunfeld, Ann-Catherine Lemonde, Ian Gold, Vincent Paquin, Srividya N. Iyer, Martin Lepage, Ridha Joober, Ashok Malla, Jai L. Shah
ImportanceDespite growing interest in the phenomenology of delusions in psychosis, at present little is known about their content and evolution over time, including whether delusion themes are consistent across episodes.ObjectiveTo examine the course of delusions and thematic delusion content across relapse episodes in patients presenting to an early intervention service for psychosis.Design, Setting
-
-
Roles That Psychiatrists Can Play in International Negotiations to Reduce Conflict. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-01 Neil Krishan Aggarwal
-
Brain Morphometry Normative Modeling-Omit Global Thickness. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-01 Jessica P Y Hua,Daniel H Mathalon
-
Brain Morphometry Normative Modeling-Omit Global Thickness-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-01 Shalaila S Haas,Ruiyang Ge,Sophia Frangou
-
Genes and Rearing-What Explains Intergenerational Transmission of PTSD? JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-01 Isabell Brikell,Christian Rück,Ralf Kuja-Halkola
-
Rural and Urban Trends in Mental Health Readmissions. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-01 Hefei Wen,Alyssa Halbisen,Kenton J Johnston,Benjamin G Druss
-
Smoking Cessation as a Priority for Psychiatrists JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-31 Robert A. Kleinman, Brian S. Barnett
This Viewpoint argues that psychiatrists should take an active role to address cigarette smoking in patients, due to the high comorbidity of tobacco use and other substance use disorders and the overlap of nicotine withdrawal symptoms with psychiatric symptoms.
-
Neighborhood Resources Associated With Psychological Trajectories and Neural Reactivity to Reward After Trauma JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-31 E. Kate Webb, Jennifer S. Stevens, Timothy D. Ely, Lauren A. M. Lebois, Sanne J H. van Rooij, Steven E. Bruce, Stacey L. House, Francesca L. Beaudoin, Xinming An, Thomas C. Neylan, Gari D. Clifford, Sarah D. Linnstaedt, Laura T. Germine, Kenneth A. Bollen, Scott L. Rauch, John P. Haran, Alan B. Storrow, Christopher Lewandowski, Paul I. Musey, Phyllis L. Hendry, Sophia Sheikh, Christopher W. Jones,
ImportanceResearch on resilience after trauma has often focused on individual-level factors (eg, ability to cope with adversity) and overlooked influential neighborhood-level factors that may help mitigate the development of posttraumatic stress disorder (PTSD).ObjectiveTo investigate whether an interaction between residential greenspace and self-reported individual resources was associated with a
-
Limitations for Assessing Optimism and Physical Functioning in Women-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-01 Hayami K Koga,JoAnn E Manson,Laura D Kubzansky
-
Limitations for Assessing Optimism and Physical Functioning in Women. JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-01 Chung-Chun Cheng,Peng-Ju Huang,Chia-Hao Hsu
-
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-24 Robert D. Gibbons, Mark Olfson, Loren Saulsberry, Mark J. Edlund, Sahar Zangeneh, Natalie Bareis, Lydia Chwastiak, Jason B. Gibbons, Ronald C. Kessler
ImportanceCommunity-level social vulnerability (SV) is associated with physical illness and premature mortality. Its association with mental health (MH) and substance use disorders (SUDs) needs further study.ObjectiveTo study associations of SV with clinical diagnoses of MH disorders, SUDs, and related treatments in the US noninstitutionalized population of adults aged 18 years and older.Design, Setting
-
Medical Debt and the Mental Health Treatment Gap Among US Adults JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-17 Kyle J. Moon, Sabriya L. Linton, Ramin Mojtabai
ImportanceMedical debt is common in the US and may hinder timely access to care for mental disorders.ObjectiveTo estimate the prevalence of medical debt among US adults with depression and anxiety and its association with delayed and forgone mental health care.Design, Setting, and ParticipantsCross-sectional, nationally representative survey study of US adult participants in the 2022 National Health
-
Classification of Suicide Attempt Risk Using Environmental and Lifestyle Factors in 3 Large Youth Cohorts JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-17 Elina Visoki, Tyler M. Moore, Xinhe Zhang, Kate T. Tran, Christina Ly, Mārtiņš M. Gataviņš, Grace E. DiDomenico, Leah Brogan, Joel A. Fein, Varun Warrier, Sinan Guloksuz, Ran Barzilay
ImportanceSuicide is the third-leading cause of death among US adolescents. Environmental and lifestyle factors influence suicidal behavior and can inform risk classification, yet quantifying and incorporating them in risk assessment presents a significant challenge for reproducibility and clinical translation.ObjectiveTo quantify the aggregate contribution of environmental and lifestyle factors to
-
Hospice Enrollment and Central Nervous System–Active Medication Prescribing to Medicare Decedents with Dementia JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-17 Lauren B. Gerlach, Lan Zhang, Joan Teno, Donovan T. Maust
This study explores the extent to which hospice enrollment is associated with CNS–active medication exposure among Medicare decedents with Alzheimer disease and related dementias.
-
Changing Neighborhood Income Deprivation Over Time, Moving in Childhood, and Adult Risk of Depression JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-17 Clive E. Sabel, Carsten Bøcker Pedersen, Sussie Antonsen, Roger T. Webb, Henriette Thisted Horsdal
ImportanceComplex biological, socioeconomic, and psychological variables combine to cause mental illnesses, with mounting evidence that early-life experiences are associated with adulthood mental health.ObjectiveTo evaluate whether changing neighborhood income deprivation and residential moves during childhood are associated with the risk of receiving a diagnosis of depression in adulthood.Design,
-
Treatment for Co-Occurring Stimulant and Opioid Use Disorders JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-10 Benjamin A. Howell, Lewei (Allison) Lin, Lara N. Coughlin
This Viewpoint explores the current barriers to implementing contingency management treatment for individuals experiencing both opioid use and stimulant use disorders in the context of high numbers of US overdoses.
-
Exploration-Exploitation and Suicidal Behavior in Borderline Personality Disorder and Depression JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-10 Aliona Tsypes, Michael N. Hallquist, Angela Ianni, Aleksandra Kaurin, Aidan G. C. Wright, Alexandre Y. Dombrovski
ImportanceClinical theory and behavioral studies suggest that people experiencing suicidal crisis are often unable to find constructive solutions or incorporate useful information into their decisions, resulting in premature convergence on suicide and neglect of better alternatives. However, prior studies of suicidal behavior have not formally examined how individuals resolve the tradeoffs between
-
Heterogeneity in Antidepressant Treatment and Major Depressive Disorder Outcomes Among Clinicians JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-10 Sarah Rathnam, Kamber L. Hart, Abhishek Sharma, Pilar F. Verhaak, Thomas H. McCoy, Finale Doshi-Velez, Roy H. Perlis
ImportanceWhile abundant work has examined patient-level differences in antidepressant treatment outcomes, little is known about the extent of clinician-level differences. Understanding these differences may be important in the development of risk models, precision treatment strategies, and more efficient systems of care.ObjectiveTo characterize differences between outpatient clinicians in treatment
-
Accelerated Intermittent Theta-Burst Stimulation and Treatment-Refractory Bipolar Depression JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-10 Yvette I. Sheline, Walid Makhoul, Alexandra S. Batzdorf, Frederick J. Nitchie, Kevin G. Lynch, Robin Cash, Nicholas L. Balderston
ImportanceBipolar disorder (BD) is chronic and disabling, with depression accounting for the majority of time with illness. Recent research demonstrated a transformative advance in the clinical efficacy of transcranial magnetic stimulation for treatment-resistant major depressive disorder (MDD) using an accelerated schedule of intermittent theta-burst stimulation (aiTBS), but the effectiveness of this
-
Tax Policy-An Understudied Approach to Reducing Cannabis Use. JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-01 Elyse R Grossman,Bethany Deeds,Carlos Blanco
-
Unintentional Intoxication or Injury and Risk for Self-Harm in Adolescents and Young Adults JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-03 Ariel Frajerman, Karine Goueslard, Catherine Quantin, Fabrice Jollant
This cohort study explores the risk of nonfatal self-harm in French adolescents and young adults hospitalized for unintentional intoxication or injury.
-
Gratitude and Mortality Among Older US Female Nurses JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-03 Ying Chen, Olivia I. Okereke, Eric S. Kim, Henning Tiemeier, Laura D. Kubzansky, Tyler J. VanderWeele
ImportanceSupporting healthy aging is a US public health priority, and gratitude is a potentially modifiable psychological factor that may enhance health and well-being in older adults. However, the association between gratitude and mortality has not been studied.ObjectiveTo examine the association of gratitude with all-cause and cause-specific mortality in later life.Design, Setting, and ParticipantsThis
-
Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-03 Moonil Kang, Clara Li, Arnav Mahajan, Jessica Spat-Lemus, Shruti Durape, Jiachen Chen, Ashita S. Gurnani, Sherral Devine, Sanford H. Auerbach, Ting Fang Alvin Ang, Richard Sherva, Wei Qiao Qiu, Kathryn L. Lunetta, Rhoda Au, Lindsay A. Farrer, Jesse Mez
ImportanceSubjective cognitive decline (SCD) is recognized to be in the Alzheimer disease (AD) cognitive continuum. The SCD Initiative International Working Group recently proposed SCD-plus (SCD+) features that increase risk for future objective cognitive decline but that have not been assessed in a large community-based setting.ObjectiveTo assess SCD risk for mild cognitive impairment (MCI), AD, and
-
Advancing Diversity, Equity, and Inclusion at JAMA Psychiatry. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Kara S Bagot,Dost Öngür
-
Errors in Numbers of Participants in Studies Included in Meta-Analysis. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Chuanjun Zhuo
-
Advancing the Blueprint to Mental Health Parity Reform. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Jacob T Kannarkat,Joseph T Kannarkat,Rachel Presskreischer
-
Clozapine Proficiency as a Milestone in Psychiatric Training. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Theodore R Zarzar
-
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Zhi-De Deng,Richard D Weiner,Sarah H Lisanby
-
Pain Scores as Secondary Outcomes-Opioid Reduction Studies-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Nina A Cooperman,Shou-En Lu,Eric L Garland
-
Pain Scores as Secondary Outcomes-Opioid Reduction Studies. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Beth B Hogans
-
Sex Differences in Autism Heritability and Likelihood: What's in a Residual? JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Alex Tsompanidis,Varun Warrier,Simon Baron-Cohen
-
Trends in Deaths of Despair by Race and Ethnicity From 1999 to 2022. JAMA Psychiatry (IF 22.5) Pub Date : 2024-07-01 Joseph Friedman,Helena Hansen
-
Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-26 Jesus J. Gomar, Jeremy Koppel
ImportanceThe emergence of psychotic symptoms in Alzheimer disease (AD) is associated with accelerated cognitive and functional decline that may be related to disease pathology.ObjectiveTo investigate the longitudinal dynamics of plasma tau phosphorylated at threonine 181 (p-tau181) and neurofilament light chain protein (NfL) levels in association with the emergence of psychotic symptoms (delusions
-
Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-26 Jurjen J. Luykx, Christoph U. Correll, Peter Manu, Antti Tanskanen, Alkomiet Hasan, Jari Tiihonen, Heidi Taipale
ImportanceAntipsychotic drugs (particularly clozapine) have been associated with pneumonia in observational studies. Despite studies of the associations between antipsychotic use and incident pneumonia, it remains unclear to what degree antipsychotic use is associated with increased risk of pneumonia, whether dose-response associations exist, and what agents are specifically associated with incident
-
Major Psychiatric Disorders, Substance Use Behaviors, and Longevity JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-18 Daniel B. Rosoff, Ali M. Hamandi, Andrew S. Bell, Lucas A. Mavromatis, Lauren M. Park, Jeesun Jung, Josephin Wagner, Falk W. Lohoff
ImportanceObservational studies suggest that major psychiatric disorders and substance use behaviors reduce longevity, making it difficult to disentangle their relationships with aging-related outcomes.ObjectiveTo evaluate the associations between the genetic liabilities for major psychiatric disorders, substance use behaviors (smoking and alcohol consumption), and longevity.Design, Settings, and ParticipantsThis
-
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-18 Wanda Tempelaar, Nicole Kozloff, Emilie Mallia, Aristotle Voineskos, Paul Kurdyak
ImportanceCharacterizing mental health service use trajectories preceding diagnosis of a psychotic disorder may help identify individuals at highest risk and in which settings they are at highest risk.ObjectiveTo examine mental health service use and diagnostic trajectories before first diagnosis of psychotic disorder and identify utilization and diagnostic patterns.Design, Setting, and ParticipantsThis
-
Integrative Modeling of Accelerometry-Derived Sleep, Physical Activity, and Circadian Rhythm Domains With Current or Remitted Major Depression JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-12 Sun Jung Kang, Andrew Leroux, Wei Guo, Debangan Dey, Marie-Pierre F. Strippoli, Junrui Di, Julien Vaucher, Pedro Marques-Vidal, Peter Vollenweider, Martin Preisig, Kathleen R. Merikangas, Vadim Zipunnikov
ImportanceAccelerometry has been increasingly used as an objective index of sleep, physical activity, and circadian rhythms in people with mood disorders. However, most prior research has focused on sleep or physical activity alone without consideration of the strong within- and cross-domain intercorrelations; and few studies have distinguished between trait and state profiles of accelerometry domains
-
Polygenic Scores and Networks of Psychopathology Symptoms JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-12 Giulia G. Piazza, Andrea G. Allegrini, Thalia C. Eley, Sacha Epskamp, Eiko Fried, Adela-Maria Isvoranu, Jonathan P. Roiser, Jean-Baptiste Pingault
ImportanceStudies on polygenic risk for psychiatric traits commonly use a disorder-level approach to phenotyping, implicitly considering disorders as homogeneous constructs; however, symptom heterogeneity is ubiquitous, with many possible combinations of symptoms falling under the same disorder umbrella. Focusing on individual symptoms may shed light on the role of polygenic risk in psychopathology
-
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-01 Martin Hautzinger,
Importance Several psychotherapy protocols have been evaluated as adjuncts to pharmacotherapy for patients with bipolar disorder (BD). Little is known about their comparative effectiveness. Objective To compare the effectiveness of 2 types of group psychotherapy, skill-oriented, material-based cognitive behavioral therapy (SEKT) and supportive, patient-centered, emotion-focused therapy (FEST), to prevent
-
Extended Swedish Adoption Study of Adverse Stress Responses and Posttraumatic Stress Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-05 Ananda B. Amstadter, Linda Abrahamsson, Shannon Cusack, Jan Sundquist, Kristina Sundquist, Kenneth S. Kendler
ImportanceTwin studies have found that posttraumatic stress disorder (PTSD) is influenced by both genetic and environmental factors within a generation. No study has used an adoption design, which can address questions about the degree and sources of cross-generational transmission of adverse stress responses (ASRs) and PTSD.ObjectivesTo examine whether ASRs or PTSD are transmitted from parents to
-
Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-01 Scott T Aaronson,Andrew van der Vaart,Harold A Sackeim
-
Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety. JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-01 Eiko I Fried,Ioana A Cristea,Florian Naudet
-
Informed Consent to Psychedelic Treatment-A Work in Progress. JAMA Psychiatry (IF 22.5) Pub Date : 2024-06-01 Paul S Appelbaum